New glycosidase activated nitric oxide donors: Glycose and 3-morphorlinosydnonimine conjugates

Journal of Organic Chemistry

Volumn 70, Issue 9, 2005, Pages 3518-3524

  Cai, T Bill ^a   Lu, Dongning ^a   Tang, Xiaoping ^a   Zhang, Yalong ^a   Landerholm, Megan ^a   Wang, Peng George ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATION ANALYSIS; AMINES; DRUG PRODUCTS; ENZYMES; NITROGEN COMPOUNDS;

ANOMERICS; BIOMEDICAL RESEARCH; GALACTOSE; GLYCOSIDASES;

GLUCOSE;

2,3,4,6 TETRA O DEXTRO GALACTOPYRANOSE; 2,3,4,6 TETRA O DEXTRO GLUCOPYRANOSE; 3 (3,4 DICHLOROPHENYL) 1,2,3,4 OXATRIAZOLE 5 IMINE; 4 NITROPHENYL(2,3,4,6 TETRAACETYL DEXTRO GALACTOPYRANOSYL) CARBONATE; 4 NITROPHENYL(2,3,4,6 TETRAACETYL DEXTRO GLUCOPYRANOSYL) CARBONATE; ALPHA GLYCOSIDE; AMPHOLYTE; BETA GLYCOSIDE; CARBAMIC ACID; CARBOHYDRATE DERIVATIVE; GALACTOSE; GLUCOSE; GLYCOSIDASE; GLYCOSIDE; LINSIDOMINE; METHYL 5 ACETAMIDO 4,7,8,9 TETRA O ACETYL 2 (4 NITROPHENOXYCARBONYLOXY) 3,5 DIDEOXY BETA DEXTRO GLYCERO DEXTRO GALACTO 2 NONULOPYRANOSONATE; N (2,3,4,6 TETRA O ACETYL BETA DEXTRO GALACTOPYRANOSYL) CARBONYL 3 MORPHOLINOSYDNONIMINE; N (2,3,4,6 TETRA O ACETYL BETA DEXTRO GALACTOPYRANOSYL)CARBONYL 3 (3,4 DICHLOROPHENYL) 1,2,3,4 OXATRIAZOLE 5 IMINE; N (2,3,4,6 TETRA O ACETYL BETA DEXTRO GLUCOPYRANOSYL) CARBONYL 3 MORPHOLINOSYDNONIMINE; N (5 ACETAMIDO 3,5 DIDEOXY BETA DEXTRO GLYCERO DEXTRO GALACTO 2 NONULOPYRANOSYL)ONATE] CARBONYL 3 MORPHOLINOSYDNONIMINE; N (BETA DEXTRO GALACTOPYRANOSYL)CARBONYL 3 MORPHOLINOSYDNONIMINE; N (BETA DEXTRO GLUCOPYRANOSYL)CARBONYL 3 MORPHOLINOSYDNONIMINE; N [METHYL (5 ACETAMIDO 4,7,8,9 TETRA O ACETYL 3,5 DIDEOXY BETA DEXTRO GLYCERO DEXTRO GALACTO 2 NONULOPYRANOSYL)ONATE] CARBONYL 3 MORPHOLINOSYDNONIMINE; N ACETYLNEURAMINIC ACID; NITRIC OXIDE DONOR; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL REACTION; CHEMICAL STRUCTURE; COVALENT BOND; ENZYME ACTIVATION; ENZYME ACTIVITY;

CATALYSIS; GLYCOSIDE HYDROLASES; GLYCOSIDES; MODELS, MOLECULAR; MOLECULAR STRUCTURE; MOLSIDOMINE; NITRIC OXIDE DONORS; PRODRUGS;

EID: 17744368707     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo050010o     Document Type: Article

References (28)

1. (a) Ignarro, L. J.; Murad, F. Nitric Oxide: Biochemistry, Molecular Biology, and Therapeutic Implications; Academic: San Diego, CA, 1995.
2. (b) Lancaster, J. Nitric Oxide: Principles and Actions; Academic: San Diego, CA 1996.
3. Fukuto, J. M.; Cho, J. Y.; Switzer, C. H. In Nitric Oxide: Biochemistry, Molecular Biology, and Therapeutic Implications; Ignarro, L. J., Ed.; Academic: San Diego, CA, 2000; pp 23-40.
4. (a) Koppenol, W. H. Free Radical Biol. Med. 1998, 25, 385.
5. (b) Murphy, M. P.; Packer, M. A.; Scarlett, J. L.; Martin, S. W. Gen. Pharmacol. 1998, 31, 179.
6. (c) Douki, T.; Cadet, J.; Ames, B. N. Chem. Res. Toxicol. 1996, 9, 3.
7. Wong, A.; Toth, I. Curr. Med. Chem. 2001, 8, 1123.
8. Hou, Y.; Wang, J.-Q.; Ramirez, J.; Wang, P. G. Methods Enzymol. 1999, 301, 242.
9. Wu, X.; Tang, X.; Xian, M.; Wang, P. G. Tetrahedron Lett. 2001, 42, 3779.
10. De Graaf, M.; Pinedo, H. M.; Quadir, R.; Haisma, H. J.; Boven, E. Biochem. Pharmacol. 2003, 65, 1875.
11. Guidotti, L. G.; McClary, H.; Loudis, J. M.; Chisari, F. V. J. Exp. Med. 2000, 191, 1247.
12. Rimmelzwaan, G. F.; Baars, M. M. J. W.; De Lijster, P.; Fouchier, R. A. M.; Osterhaus, A. D. M. E. J. Virol. 1999, 73, 8880.
13. (a) Schonafinger, K. IL Farmaco 1999, 54, 316.
14. (b) Newton, C. G.; Ramsden, C. A. Tetrahedron 1982, 38, 2965.
15. Virag, L.; Szabo, E.; Gergely, P.; Szabo, C. Toxicol. Lett. 2003, 140-141, 113.
16. Masuda, K.; Imashiro, Y.; Kaneko, T. Chem. Pharm. Bull. 1970, 18, 128.
17. Sim, M. M.; Kondo, H.; Wong, C.-H. J. Am. Chem. Soc. 1993, 115, 2260.
18. Azoulay, M.; Escriou, V.; Florent, J.-C.; Monneret, C. J. Carbodydr. Chem. 2001, 20, 841.
19. (a) Karup, G.; Preikschat, H.; Wilhelmsen, E. S.; Pedersen, S. B.; Marcinkiewicz, E.; Cieslik, K.; Gryglewski, R. J. Pol. J. Pharmacol. 1994, 46, 541.
20. (b) Corell, T.; Pedersen, S. B.; Lissau, B.; Moilanen, E.; Metsae-Ketelae, T.; Kankaanranta, H.; Vuorinen, P.; Vapaatalo, H.; Rydell, E.; Andersson, R.; Marcinkiewicz, E.; Korbut, R.; Gryglewski, R. J. Pol. J. Pharmacol. 1994, 46, 553.
21. Karup, G. L.; Preikschat, H. F.; Corell, T. N.; Lissau, B. G.; Clausen, F. P.; Petersen, S. B.; Alhede, B. I. F. WO Patent 9213847, 1992; CA 118:38925.
22. Marra, A.; Sinay, P. Carbohydr. Res. 1989, 190, 317.
23. Dabrowski, U.; Friebolin, R.; Brossmer, R.; Supp, M. Tetahedron Lett. 1979, 48, 4637.
24. Green, L. C.; Wagner, D. A.; Glogowski, J.; Skipper, P. L.; Wishnok, J. S.; Tannenbaum, S. R. Anal. Biochem. 1982, 126, 131.
25. Ullrich, T.; Oberle, S.; Abate, A.; Schroder, H. FEBS Lett. 1997, 406, 66.
26. Bohn, H.; Schonafinger, K. J. Cardiovasc. Pharmacol. 1989, 14 (Suppl. 11), S6.
27. Huie, R. E.; Padmaja, S. Free Radical Res. Commun. 1993, 18, 195.
28. Bandgar, B. P.; Hartmann, M.; Schmid, W.; Zbiral, E. Justus Liebigs Ann. Chem. 1990, 1185.